|
|
|
Volumn 14 Suppl 2, Issue , 2008, Pages
|
|
Is there a role for infliximab in the treatment of severe ulcerative colitis?: the American experience.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
DRUG COMBINATION;
HOSPITALIZATION;
HUMAN;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
TREATMENT OUTCOME;
ULCERATIVE COLITIS;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
COLITIS, ULCERATIVE;
DRUG THERAPY, COMBINATION;
HUMANS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 70349928725
PISSN: None
EISSN: 15364844
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (8)
|
